Merck KGaA

(ETR) MRK

Current Price€130.75

Market Cap€56.89B

Since IPO (1995)+1,398%

5 Year-9%

1 Year+14%

1 Month+19%

Merck KGaA Financials at a Glance

Market Cap

€56.89B

Revenue (TTM)

€20.96B

Net Income (TTM)

€2.53B

EPS (TTM)

€5.82

P/E Ratio

22.47

Dividend

€2.20

Beta (Volatility)

0.00 (Low)

Dividend

€2.20

Beta (Volatility)

0.00 (Low)

Price

€130.75

Volume

285,652

Open

€131.90

Price

€130.75

Volume

285,652

Open

€131.90

Previous Close

€130.75

Daily Range

€129.85 - €132.30

52-Week Range

€100.70 - €132.30

Dividend

€2.20

Beta (Volatility)

0.00 (Low)

Price

€130.75

Volume

285,652

Open

€131.90

Previous Close

€130.75

Daily Range

€129.85 - €132.30

52-Week Range

€100.70 - €132.30

MRK News

This New Product Is Central to mRNA Vaccines -- But Should You Buy the Stock?

Alex CarchidiJun 9, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Merck KGaA

Industry

Pharmaceuticals

Sector

Health Care

Employees

62,477

CEO

Belén Garijo López, MD

Website

www.merckgroup.com

Headquarters

Darmstadt, 64293, DE

MRK Financials

Key Financial Metrics (TTM)

Gross Margin

59%

Operating Margin

19%

Net Income Margin

12%

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

4.45%

Dividend Yield

1.68%

Payout Ratio

11.76%

Stock Overview

Market Cap

€56.89B

Shares Outstanding

434.78M

Volume

285.65K

Avg. Volume

380.64K

Financials (TTM)

Gross Profit

€11.89B

Operating Income

€4.07B

EBITDA

€5.95B

Operating Cash Flow

€3.93B

Capital Expenditure

-€1.58B

Free Cash Flow

€2.35B

Cash & ST Invst.

€2.74B

Total Debt

€11.97B

Merck KGaA Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

€5.13B

-2.8%

Gross Profit

€3.07B

-2.5%

Gross Margin

59.70%

N/A

Market Cap

€56.89B

N/A

Market Cap/Employee

€963.92K

N/A

Employees

59,020

N/A

Net Income

€660.00M

-10.2%

EBITDA

€1.49B

-9.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

-€9.30B

-31.3%

Accounts Receivable

€4.78B

+6.9%

Inventory

€4.78B

+6.0%

Long Term Debt

€10.80B

N/A

Short Term Debt

€1.24B

-28.7%

Return on Assets

4.77%

N/A

Return on Invested Capital

9.30%

N/A

Free Cash Flow

€365.00M

+1040.6%

Operating Cash Flow

€818.00M

+47.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,606.84+0.00%

^DJIDJI

^DJIDJI$51,304.31+0.00%

^IXICNASDAQ

^IXICNASDAQ$27,069.44-0.00%

BTCBitcoin

BTCBitcoin$67,519.00-0.05%

AAPLAAPL

AAPLAAPL$313.92+0.02%

AMZNAMZN

AMZNAMZN$258.26-0.01%

GOOGGOOG

GOOGGOOG$362.18-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

HPEHewlett Packard Enterprise

HPEHewlett Packard Enterprise$56.15+0.19%

NOKNokia

NOKNokia$16.85+0.04%

INTCIntel

INTCIntel$107.93-0.01%

ONDSOndas

ONDSOndas$13.58+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$17.74-0.05%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$38.05-0.06%

FFord Motor Company

FFord Motor Company$16.15-0.03%

Questions About MRK

What is the current price of Merck KGaA?

Merck KGaA is trading at €130.75 per share.

What is the 52-week range for Merck KGaA?

Over the past 52 weeks, Merck KGaA has traded between €100.70 and €132.30.

How much debt does Merck KGaA have?

As of the most recent reporting period, Merck KGaA reported total debt of €12.04B.

How much cash does Merck KGaA have on hand?

Merck KGaA reported €2.74B in cash and cash equivalents in its most recent financial results.

What is Merck KGaA’s dividend yield?

Merck KGaA currently has a dividend yield of 1.68%.

Merck KGaA

Merck KGaA Financials at a Glance

MRK News

This New Product Is Central to mRNA Vaccines -- But Should You Buy the Stock?

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Merck KGaA

MRK Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Merck KGaA Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MRK

What is the current price of Merck KGaA?

What is the 52-week range for Merck KGaA?

How much debt does Merck KGaA have?

How much cash does Merck KGaA have on hand?

What is Merck KGaA’s dividend yield?

Premium Investing Services